Literature DB >> 3913528

Liposomes for oral administration of drugs.

J F Woodley.   

Abstract

In the late 1970s liposome-entrapped insulin was administered by the oral route to both normal and diabetic animals. Results showed that small but significant amounts of insulin could reach the circulation. However, different liposome compositions gave varied results and no mechanism of absorption was elucidated. Subsequent in vitro studies suggested that many liposome compositions used were unstable in the conditions prevailing in the gastrointestinal tract. Using more stable liposomes in an everted gut system, it has been demonstrated that liposomes were pinocytosed by intestinal epithelial cells and transferred to the serosal side of the gut. Recent studies both in vitro and in vivo show that there may be the possibility of enhancing the uptake process to deliver a range of drugs by the oral route.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3913528

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  10 in total

1.  Solubilization of liposomes by weak electrolyte drugs. I. Propranolol.

Authors:  J A Rogers; G V Betageri; Y W Choi
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

Review 2.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

Review 3.  Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.

Authors:  W Blair Geho; Hans C Geho; John R Lau; Theophilus J Gana
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

4.  Archaeosome: as new drug carrier for delivery of Paclitaxel to breast cancer.

Authors:  Seyed Ebrahim Alavi; Hamidreza Mansouri; Maedeh Koohi Moftakhari Esfahani; Fatemeh Movahedi; Azim Akbarzadeh; Mohsen Chiani
Journal:  Indian J Clin Biochem       Date:  2013-02-12

5.  Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats.

Authors:  N Ammoury; H Fessi; J P Devissaguet; M Dubrasquet; S Benita
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

6.  Study of toxicity effect of pegylated nanoliposomal artemisinin on breast cancer cell line.

Authors:  Neda Dadgar; Seyed Ebrahim Alavi; Maedeh Koohi Moftakhari Esfahani; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-02-10

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

8.  Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells.

Authors:  Xiaobo Luo; Rongfa Guan; Xiaoqiang Chen; Miao Tao; Jieqing Ma; Jin Zhao
Journal:  Nanoscale Res Lett       Date:  2014-06-10       Impact factor: 4.703

Review 9.  Natural Polysaccharide-Based Nanodrug Delivery Systems for Treatment of Diabetes.

Authors:  Aijun Qiu; Yunyun Wang; Genlin Zhang; Hebin Wang
Journal:  Polymers (Basel)       Date:  2022-08-08       Impact factor: 4.967

10.  Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury.

Authors:  Janelle L Davis; Hunter L Paris; Joseph W Beals; Scott E Binns; Gregory R Giordano; Rebecca L Scalzo; Melani M Schweder; Emek Blair; Christopher Bell
Journal:  Nutr Metab Insights       Date:  2016-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.